Article Information
History
- April 18, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 18, 2020 - 02:51).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Daniela Weiskopf1,#,
- Katharina S. Schmitz2,#,
- Matthijs P. Raadsen2,
- Alba Grifoni1,
- Nisreen M.A. Okba2,
- Henrik Endeman3,
- Johannes P.C. van den Akker3,
- Richard Molenkamp2,
- Marion P.G. Koopmans2,
- Eric C.M. van Gorp2,
- Bart L. Haagmans2,
- Rik L. de Swart2,
- Alessandro Sette4,5,$ and
- Rory D. de Vries2,$,*
- 1Center for Infectious Disease, La Jolla Institute for Immunology, La Jolla, CA92037, USA
- 2Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
- 3Department of Intensive Care, Erasmus MC, Rotterdam, the Netherlands
- 4Department of Pathology, University of California, San Diego, CA92037, USA
- 5Department of Medicine, University of California, San Diego, CA92037, USA
- ↵* author for correspondence: r.d.devries{at}erasmusmc.nl
Posted April 18, 2020.
Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome
